Header Logo

Connection

Carl Maki to Retinoblastoma Protein

This is a "connection" page, showing publications Carl Maki has written about Retinoblastoma Protein.
Connection Strength

0.227
  1. CSE1L is a negative regulator of the RB-DREAM pathway in p53 wild-type NSCLC and can be targeted using an HDAC1/2 inhibitor. Sci Rep. 2023 09 27; 13(1):16271.
    View in: PubMed
    Score: 0.227
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.